Cagrisema is a combination medication for weight management and type 2 diabetes, consisting of two active ingredients:

• Cagrilintide – A long-acting amylin analogue (similar to the hormone amylin, which helps regulate appetite and blood sugar).
•  – A GLP-1 receptor agonist (which slows gastric emptying, reduces appetite, and improves insulin secretion).

How Does CagriSema Work?

• Appetite Suppression – Both drugs act on brain receptors to increase satiety and reduce hunger.
• Slowed Gastric Emptying – Delays stomach emptying, making you feel full longer.
• Blood Sugar Control – Improves insulin sensitivity and reduces glucagon secretion.
• Weight Loss – Combined effects lead to significant reductions in body weight.

Current Research status 

• REDEFINE 1 & 2 for obesity and type 2 diabetes).

For Research Use Only – Not for Human or Animal Consumption